Population
DNA samples from subjects affected by facioscapulohumeral muscular dystrophy (FSHD) and unaffected subjects
Design
Preclinical
Authors
Loading...
May refine FSHD allele distinction in animal models; leaves open human validation before diagnostic use.
Differential restriction using BlnI improves the reliability of Southern blots for diagnosing FSHD by distinguishing 4q35 from 10q26 alleles.
Deidda et al. (1996) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: